Actively Recruiting
Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)
Led by University of California, San Diego · Updated on 2025-07-17
225
Participants Needed
1
Research Sites
225 weeks
Total Duration
On this page
Sponsors
U
University of California, San Diego
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The researchers hope to learn if specific types of MRI software and techniques can help improve early prostate cancer detection at time of a MRI-guided prostate biopsy.
CONDITIONS
Official Title
Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Selected to undergo an MRI-fusion prostate needle biopsy of the prostate.
- Able to provide informed consent
You will not qualify if you...
- Prior diagnosis of prostate cancer (Grade Group >1)
- Metastatic prostate cancer
- Prior prostate cancer treatment
- Contraindication to prostate biopsy (e.g., on anticoagulation that cannot be safely discontinued)
- Inability to undergo MRI (e.g., too large to be accommodated in a scanner or with an implant incompatible with MRI)
- Bilateral hip replacement
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, San Diego
La Jolla, California, United States, 92093
Actively Recruiting
Research Team
M
Michael A Liss, MD, PhD
CONTACT
J
Jessica Warbrick, ND
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here